Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125182) titled 'The influence of esketamine on postoperative sleep disorders in patients with thyroid cancer' on May 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Affiliated Hospital of Zunyi Medical University
Condition:
Postoperative sleep disorders in patients with thyroid cancer
Intervention:
Group L:Before anesthesia induction, 0.3mg/kg of esketamine was intravenously injected.
Group H:Before anesthesia induction, 0.5mg/kg of esketamine was intravenously injected.
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-05-25
Target Sample Size: Group L:40;Group ...